Overall rank by patents
#5,877
Across all tracked assignees
USPTO PatentsView assignee record - 58 granted patents across 19 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Riverpoint holds 58 US patents across 19 technology areas, rank #5,877 of 50,000 tracked assignees.
Riverpoint Medical, Llc has been granted 58 US utility patents between 2015 and 2025, placing Riverpoint Medical, Llc at rank #5,877 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Riverpoint Medical, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Riverpoint sits between Riken Technos Corporation (58 patents, rank #5,873) and SOFT Robotics, Inc. (58 patents, rank #5,881) - the closest US assignees by grant volume. The composite Innovation Score of 41.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 36 grants, compared with 22 in the 2015–2019 window, a +64% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Riverpoint Medical, Llc's 11.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Riverpoint Medical, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
RIKEN TECHNOS CORPORATION
58 patents
RTIC IP, LLC
58 patents
RareCyte, Inc.
58 patents
Real Value LLC
58 patents
SAKATA INX CORPORATION
58 patents
SAMI LABS LIMITED
58 patents
SEOUL NATIONAL UNIVERSITY HOSPITAL
58 patents
SOFT ROBOTICS, INC.
58 patents
Riverpoint Medical, LLC
58 patents
What this shows Riverpoint holds 58 patents at rank #5,877, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,877 in granted patent volume.
Other assignees with the most granted patents in Riverpoint's primary technology class.
Riverpoint's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 3.4% |
| 2016 | 6 | 10.3% |
| 2017 | 7 | 12.1% |
| 2018 | 2 | 3.4% |
| 2019 | 5 | 8.6% |
| 2020 | 10 | 17.2% |
| 2021 | 9 | 15.5% |
| 2022 | 7 | 12.1% |
| 2023 | 6 | 10.3% |
| 2024 | 3 | 5.2% |
| 2025 | 1 | 1.7% |
Top 15 of 19 technology areas
Overall rank by patents
#5,877
Across all tracked assignees
41.0 out of 100
How to use this portfolio
Riverpoint's 58 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.